S R Goldstein

Summary

Affiliation: New York University
Country: USA

Publications

  1. ncbi Evaluation of endometrial polyps
    Steven R Goldstein
    Department of Obstetrics and Gynecology, Division of Obstetrics and Gynecology Pathology, New York University School of Medicine, New York, NY, USA
    Am J Obstet Gynecol 186:669-74. 2002
  2. ncbi Abnormal uterine bleeding: the role of ultrasound
    Steven R Goldstein
    New York University School of Medicine, 530 First Avenue, Suite 10N, New York, NY 10016, USA
    Radiol Clin North Am 44:901-10. 2006
  3. ncbi Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass
    Steven R Goldstein
    New York University School of Medicine, New York, NY 10016, USA
    Menopause 19:41-7. 2012
  4. ncbi Raloxifene use in clinical practice: efficacy and safety
    Steven R Goldstein
    New York University School of Medicine, New York, NY 10016, USA
    Menopause 16:413-21. 2009
  5. ncbi Early pregnancy: normal and abnormal
    Steven R Goldstein
    New York University School of Medicine, New York, New York 10016, USA
    Semin Reprod Med 26:277-83. 2008
  6. ncbi Accreditation, certification: why all the confusion?
    Steven R Goldstein
    New York University Medical Center, New York, New York 10016, USA
    Obstet Gynecol 110:1396-8. 2007
  7. ncbi Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen
    Steven R Goldstein
    Department of Ob Gyn, New York University Medical Center, New York, NY 10016, USA
    Menopause 12:160-4. 2005
  8. ncbi The case for less-than-monthly progestogen in women on HT: is transvaginal ultrasound the key?
    Steven R Goldstein
    New York University School of Medicine, 530 First Avenue, Suite 10N, New York, NY 10016, USA
    Menopause 12:110-3. 2005
  9. ncbi Menorrhagia and abnormal bleeding before the menopause
    Steven R Goldstein
    Department of Obstetrics and Gynecology, New York University Medical Center, School of Medicine, 530 First Avenue, Suite 10N, New York, NY 10016, USA
    Best Pract Res Clin Obstet Gynaecol 18:59-69. 2004
  10. ncbi An update on non-uterine gynaecological effects on raloxifene
    S R Goldstein
    New York University School of Medicine, 530 First Avenue, Suite 10N, New York, NY 10016, USA
    Eur J Cancer 38:S65-6. 2002

Detail Information

Publications32

  1. ncbi Evaluation of endometrial polyps
    Steven R Goldstein
    Department of Obstetrics and Gynecology, Division of Obstetrics and Gynecology Pathology, New York University School of Medicine, New York, NY, USA
    Am J Obstet Gynecol 186:669-74. 2002
    ..The potential benefit of a noninvasive technique to distinguish benign from malignant polyps is obvious. This study was undertaken to evaluate endometrial polyps by color flow Doppler ultrasound scanning and histopathologic examination...
  2. ncbi Abnormal uterine bleeding: the role of ultrasound
    Steven R Goldstein
    New York University School of Medicine, 530 First Avenue, Suite 10N, New York, NY 10016, USA
    Radiol Clin North Am 44:901-10. 2006
    ....
  3. ncbi Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass
    Steven R Goldstein
    New York University School of Medicine, New York, NY 10016, USA
    Menopause 19:41-7. 2012
    ..The aim of this study was to report the gynecologic safety findings from the Generations trial, a phase 3 study of the selective estrogen receptor modulator (SERM), arzoxifene...
  4. ncbi Raloxifene use in clinical practice: efficacy and safety
    Steven R Goldstein
    New York University School of Medicine, New York, NY 10016, USA
    Menopause 16:413-21. 2009
    ..In this article, we provide an interdisciplinary concise review of the effects of raloxifene on breast, bone, and reproductive organs, as well as the adverse events that may be associated with its use...
  5. ncbi Early pregnancy: normal and abnormal
    Steven R Goldstein
    New York University School of Medicine, New York, New York 10016, USA
    Semin Reprod Med 26:277-83. 2008
    ..This article will review the fundamental principals outlined above...
  6. ncbi Accreditation, certification: why all the confusion?
    Steven R Goldstein
    New York University Medical Center, New York, New York 10016, USA
    Obstet Gynecol 110:1396-8. 2007
    ..Obstetrician-gynecologists should realize that AIUM's accreditation is their "lifeboat" in this time of increasing interference by health care insurers into decision making in clinical practice...
  7. ncbi Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen
    Steven R Goldstein
    Department of Ob Gyn, New York University Medical Center, New York, NY 10016, USA
    Menopause 12:160-4. 2005
    ..Determine the effect of raloxifene or estrogen, as compared with placebo, on the reporting of urinary incontinence in postmenopausal women participating in an osteoporosis prevention trial...
  8. ncbi The case for less-than-monthly progestogen in women on HT: is transvaginal ultrasound the key?
    Steven R Goldstein
    New York University School of Medicine, 530 First Avenue, Suite 10N, New York, NY 10016, USA
    Menopause 12:110-3. 2005
    ..Such an approach will allow a large number of patients whose initial endometrial echo is easily visualized to minimize their progestogen dose...
  9. ncbi Menorrhagia and abnormal bleeding before the menopause
    Steven R Goldstein
    Department of Obstetrics and Gynecology, New York University Medical Center, School of Medicine, 530 First Avenue, Suite 10N, New York, NY 10016, USA
    Best Pract Res Clin Obstet Gynaecol 18:59-69. 2004
    ....
  10. ncbi An update on non-uterine gynaecological effects on raloxifene
    S R Goldstein
    New York University School of Medicine, 530 First Avenue, Suite 10N, New York, NY 10016, USA
    Eur J Cancer 38:S65-6. 2002
  11. ncbi Update on raloxifene to prevent endometrial-breast cancer
    S R Goldstein
    New York University School of Medicine, 530 First Avenue Suite 10N, New York, NY 10016, USA
    Eur J Cancer 36:S54-6. 2000
    ..Further studies with breast cancer as a primary endpoint are ongoing (the STAR Trial)...
  12. ncbi The effect of SERMs on the endometrium
    S R Goldstein
    Department of Obstetrics and Gynecology, New York University School of Medicine, New York 10016, USA
    Ann N Y Acad Sci 949:237-42. 2001
    ..01. Thus, the risk appears to be confined to women over 50 because, in contrast, in women under 50 there was no statistically significant increase in the risk of endometrial carcinoma...
  13. ncbi Raloxifene effect on frequency of surgery for pelvic floor relaxation
    S R Goldstein
    Department of Obstetrics and Gynecology, New York University Medical Center, New York, New York, USA
    Obstet Gynecol 98:91-6. 2001
    ..To assess the effects of raloxifene therapy on the frequency of surgery for pelvic floor relaxation in postmenopausal women...
  14. ncbi Controversy about uterine effects and safety of SERMs: the saga continues
    Steven R Goldstein
    Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York 10016, USA
    Menopause 9:381-4. 2002
    ..01 (95% CI= 1.70, 10.90). The existence of potentially high- and low-risk groups should be taken into account in any future clinical trials looking at the endometrial safety of selective estrogen receptor modulators (SERMs)...
  15. ncbi Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study
    Steven R Goldstein
    Department of Obstetrics and Gynecology, New York University School of Medicine, NY, USA
    Am J Obstet Gynecol 187:521-7. 2002
    ..Levormeloxifene is a selective estrogen receptor modulator that was developed for the purpose of the treatment and prevention of postmenopausal osteoporosis...
  16. ncbi The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the menopausal endometrium
    Steven R Goldstein
    Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA
    Am J Obstet Gynecol 201:5-11. 2009
    ..The significance of a thick endometrial echo in nonbleeding postmenopausal women has not been validated and need not require automatic tissue sampling...
  17. ncbi Not all selective estrogen response modulators are created equal: update on lasofoxifene
    S R Goldstein
    Department of Obstetrics and Gynecology, New York University School of Medicine, New York, USA
    Int J Gynecol Cancer 16:504. 2006
  18. ncbi Transvaginal ultrasound-assisted gynecologic surgery: evaluation of a new device to improve safety of intrauterine surgery
    Ilan E Timor-Tritsch
    Department of Obstetrics and Gynecology, New York University School of Medicine, NY 10016, USA
    Am J Obstet Gynecol 189:1074-9. 2003
    ....
  19. ncbi Modern evaluation of the endometrium
    Steven R Goldstein
    New York University School of Medicine, New York, New York 10016, USA
    Obstet Gynecol 116:168-76. 2010
    ..Finally, the incidence of thick endometrial echo found incidentally in postmenopausal women with no bleeding is extremely high (10-17%) and should not trigger invasive endometrial sampling automatically...
  20. ncbi Transrectal scanning: an alternative when transvaginal scanning is not feasible
    I E Timor-Tritsch
    Division of Obstetric and Gynecological Ultrasound, Department of Obstetrics and Gynecology, NYU School of Medicine, New York, USA
    Ultrasound Obstet Gynecol 21:473-9. 2003
    ..Transrectal scanning is proposed mostly for ultrasound guidance in draining a pelvic abscess. Our aim was to investigate the applicability of transrectal scanning (TRS) for cases in which TVS is impossible...
  21. ncbi The endometrial echo revisited: have we created a monster?
    Steven R Goldstein
    Department of Obstetrics and Gynecology, New York University School of Medicine, 530 First Avenue, Suite 10N, New York, NY 10016, USA
    Am J Obstet Gynecol 191:1092-6. 2004
    ....
  22. ncbi Ultrasound scanning in reproductive medicine and infertility. Preface
    Steven R Goldstein
    New York University School of Medicine, New York, New York, USA
    Semin Reprod Med 26:215. 2008
  23. ncbi The effect of raloxifene on the incidence of ovarian cancer in postmenopausal women
    Patrick Neven
    Department of Obstetrics and Gynecology, Algemene Kliniek St Jan, Broekstraat 114, B 1000 Brussels, Belgium
    Gynecol Oncol 85:388-90. 2002
    ..The aim of this study was to determine the incidence of ovarian cancer in postmenopausal women treated with raloxifene compared with placebo...
  24. ncbi Raloxifene vs tamoxifen
    Steven R Goldstein
    JAMA 297:263-4; author reply 264. 2007
  25. ncbi Electrical impedance scanning as a new breast cancer risk stratification tool for young women
    Alexander Stojadinovic
    Department of Surgery, Walter Reed Army Medical Center, Washington, DC, USA
    J Surg Oncol 97:112-20. 2008
    ..The T-Scan(tm2000 (ED is designed to use EIS to identify women ages 30-39 with elevated risk of breast cancer (i.e., T-Scan+ women)...
  26. ncbi Not all SERMs are created equal
    Steven R Goldstein
    Menopause 13:325-7. 2006
  27. ncbi To the editor. Use of transvaginal ultrasonography and sonohysterography
    Steven R Goldstein
    Menopause 15:402; author reply 403-4. 2008
  28. ncbi ACOG technology assessment in obstetrics and gynecology. Number 3, September 2003. Saline infusion sonohysterography
    Daniel Breitkopf
    Obstet Gynecol 102:659-62. 2003
    ..Portions of this document were developed jointly with the American College of Radiology and the American Institute of Ultrasound in Medicine...
  29. ncbi The complexity of a "complex mass" and the simplicity of a "simple cyst"
    Ilan E Timor-Tritsch
    J Ultrasound Med 24:255-8. 2005
  30. ncbi Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society
    Wulf H Utian
    Menopause 15:584-602. 2008
    ..The benefit-risk ratio for menopausal HT is favorable close to menopause but decreases with aging and with time since menopause in previously untreated women...
  31. ncbi Routine use of office gynecologic ultrasound
    Steven R Goldstein
    J Ultrasound Med 21:489-92. 2002
  32. ncbi Attempt to reduce the progestogen component in hormone therapy
    Steven R Goldstein
    Menopause 13:538; author reply 538. 2006